Baricitinib Closer to Obtaining European Approval for Treatment of Rheumatoid Arthritis
News, rheumatoid arthritis
European regulators have taken a key step toward approving baricitinib to treat those with moderate to severe rheumatoid arthritis (RA). The European Medicines Agency’s Committee for Medicinal Products for Human Use ... Read more